SB
Samsara BioCapital, L.P. Other
US US · SEC (Form 4)
Discover the detailed record of transactions filed by Samsara BioCapital, L.P.. Insider active across 1 companies, notably Graphite Bio, Inc.. Aggregated, 15 disclosures have been recorded. Total volume traded: €9.3m. The latest transaction was filed on 11 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations 15 total
€278,608 74,464 shares @ €3.7415 3.0% of flow
Common Stock
SEC:0001209191-22-024364:0 · 11 Apr 2022
Ideal exit: 6 Jan 2023 (T+270) €794,608 100,000 shares @ €7.9461 8.5% of flow
Common Stock
SEC:0001209191-22-004735:0 · 21 Jan 2022
Ideal exit: 18 Oct 2022 (T+270) €794,608 100,000 shares @ €7.9461 17.6% of flow
Common Stock
SEC:0001209191-22-004735 · 21 Jan 2022
Ideal exit: 18 Oct 2022 (T+270) €445,010 54,565 shares @ €8.1556 9.9% of flow
Common Stock
SEC:0001209191-22-004346 · 19 Jan 2022
Ideal exit: 16 Oct 2022 (T+270) €445,010 54,565 shares @ €8.1556 4.8% of flow
Common Stock
SEC:0001209191-22-004346:0 · 19 Jan 2022
Ideal exit: 16 Oct 2022 (T+270) €202,049 22,329 shares @ €9.0487 4.5% of flow
Common Stock
SEC:0001209191-21-070500 · 15 Dec 2021
Ideal exit: 11 Sept 2022 (T+270) €202,049 22,329 shares @ €9.0487 2.2% of flow
Common Stock
SEC:0001209191-21-070500:0 · 15 Dec 2021
Ideal exit: 11 Sept 2022 (T+270) €2m 201,685 shares @ €9.0016 40.3% of flow
Common Stock
SEC:0001209191-21-066742 · 22 Nov 2021
Ideal exit: 19 Aug 2022 (T+270) €2m 201,685 shares @ €9.0016 19.5% of flow
Common Stock
SEC:0001209191-21-066742:0 · 22 Nov 2021
Ideal exit: 19 Aug 2022 (T+270) €517,422 45,400 shares @ €11.397 11.5% of flow
Common Stock
SEC:0001209191-21-060627 · 13 Oct 2021
Ideal exit: 10 Jul 2022 (T+270) €517,422 45,400 shares @ €11.397 5.6% of flow
Common Stock
SEC:0001209191-21-060627:0 · 13 Oct 2021
Ideal exit: 10 Jul 2022 (T+270) €735,762 61,475 shares @ €11.9685 16.3% of flow
Common Stock
SEC:0001209191-21-060060 · 6 Oct 2021
Ideal exit: 3 Jul 2022 (T+270) €735,762 61,475 shares @ €11.9685 7.9% of flow
Common Stock
SEC:0001209191-21-060060:0 · 6 Oct 2021
Ideal exit: 3 Jul 2022 (T+270) 6,167,763 shares
Common Stock
SEC:0001209191-21-044507 · 29 Jun 2021
6,167,763 shares
Common Stock
SEC:0001209191-21-044507:0 · 29 Jun 2021
About Samsara BioCapital, L.P. Samsara BioCapital, L.P. is an investor in Graphite Bio, Inc. and plays a key role in the company's funding.